Closing Out 2023 With Thoughts From Our Leadership Team

2023 has been a year of growth and success for Torigen, and we are happy to be reflecting on it. We brought in over 10 new team members, opened our new 7,800 square foot production facility headquarters, and created over 1,000 vaccines to help animals with cancer. 

With that in mind, we’d like to share some highlights from our leadership team from their perspectives on the past year.

2023 has been an amazing year of growth and success at Torigen and we couldn't have done it without you. We’ve continued to work on improving the lives of pets by giving veterinarians and pet parents alike more options in the fight against cancer. We are very excited to see what 2024 has in store for Torigen, and we’re expecting it to be just as successful, if not more, than 2023!